Alak AM et al. |
An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay. |
1997 |
J Pharm Biomed Anal |
pmid:9447546
|
Butcher SP et al. |
Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. |
1997 |
J. Neurosci. |
pmid:9278529
|
Singh N et al. |
Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9447904
|
Vaden SL |
Cyclosporine and tacrolimus. |
1997 |
Semin. Vet. Med. Surg. Small Anim. |
pmid:9283240
|
Hayashi S et al. |
Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). |
1997 |
Transplant. Proc. |
pmid:9193595
|
Wallemacq PE et al. |
IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. |
1997 |
Clin. Chem. |
pmid:9342026
|
Hohage H et al. |
Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients. |
1997 |
Clin Transplant |
pmid:9193847
|
Gold BG et al. |
A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. |
1997 |
Exp. Neurol. |
pmid:9344552
|
Katari SR et al. |
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. |
1997 |
Clin Transplant |
pmid:9193849
|
Ciancio G et al. |
Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. |
1997 |
Clin Transplant |
pmid:9193850
|
Jindal RM |
Post-transplant hyperlipidaemia. |
1997 |
Postgrad Med J |
pmid:9497947
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Cameron AM et al. |
FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. |
1997 |
J. Biol. Chem. |
pmid:9346894
|
Sugitani A et al. |
En bloc pancreas and kidney transplantation in a patient with limited vascular access. |
1997 |
Transplantation |
pmid:9197366
|
Hosoi R et al. |
Isoform-specific up-regulation by ouabain of Na+,K+-ATPase in cultured rat astrocytes. |
1997 |
J. Neurochem. |
pmid:9349566
|
Guerini D |
Calcineurin: not just a simple protein phosphatase. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9199180
|
Krüger M et al. |
Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. |
1997 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:9349628
|
Rouviere N et al. |
Immunosuppressor binding to the immunophilin FKBP59 affects the local structural dynamics of a surface beta-strand: time-resolved fluorescence study. |
1997 |
Biochemistry |
pmid:9200682
|
Prokisch H et al. |
Impairment of calcineurin function in Neurospora crassa reveals its essential role in hyphal growth, morphology and maintenance of the apical Ca2+ gradient. |
1997 |
Mol. Gen. Genet. |
pmid:9349701
|
Alak AM |
Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. |
1997 |
Ther Drug Monit |
pmid:9200777
|
Saitoh O et al. |
Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29). |
1997 |
J. Gastroenterol. |
pmid:9349985
|
Hebebrand D et al. |
Nerve xenograft transplantation. Immunosuppression with FK-506 and RS-61443. |
1997 |
J Hand Surg Br |
pmid:9222906
|
Kageyama M et al. |
FK506-binding proteins regulate smooth muscle contractility by altering neurotransmitter release. |
1997 |
Eur. J. Pharmacol. |
pmid:9314039
|
Rejto PA and Verkhivker GM |
Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity. |
1997 |
Proteins |
pmid:9223178
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Midtvedt K et al. |
Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment. |
1997 |
Nephrol. Dial. Transplant. |
pmid:9430893
|
Kiuchi T et al. |
A hepatic graft tuberculosis transmitted from a living-related donor. |
1997 |
Transplantation |
pmid:9089234
|
Paterson DL and Singh N |
Interactions between tacrolimus and antimicrobial agents. |
1997 |
Clin. Infect. Dis. |
pmid:9431391
|
Krämer BK and Schweda F |
Differing proteinuria control with cyclosporin and tacrolimus. |
1997 |
Lancet |
pmid:9093272
|
Openshaw H |
Peripheral neuropathy after bone marrow transplantation. |
1997 |
Biol. Blood Marrow Transplant. |
pmid:9360782
|
Maurer M et al. |
Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. |
1997 |
Am. J. Pathol. |
pmid:9094998
|
Rinaldi M et al. |
FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. |
1997 |
J. Heart Lung Transplant. |
pmid:9361242
|
Steiner JP et al. |
Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. |
1997 |
Nat. Med. |
pmid:9095176
|
Nakai A et al. |
The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat. |
1997 |
Neurobiol. Dis. |
pmid:9361306
|
Reyes J et al. |
Graft-versus-host disease after liver and small bowel transplantation in a child. |
1997 |
Clin Transplant |
pmid:9361921
|
Blau CA et al. |
A proliferation switch for genetically modified cells. |
1997 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9096348
|
Neu AM et al. |
Evaluation of neurotoxicity in pediatric renal transplant recipients treated with tacrolimus (FK506). |
1997 |
Clin Transplant |
pmid:9361932
|
Garcia-Morales R et al. |
The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. |
1997 |
J. Clin. Invest. |
pmid:9062371
|
Xenos EX et al. |
The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. |
1997 |
Clin Transplant |
pmid:9361949
|
Göthel SF et al. |
An internal FK506-binding domain is the catalytic core of the prolyl isomerase activity associated with the Bacillus subtilis trigger factor. |
1997 |
Eur. J. Biochem. |
pmid:9063446
|
Dumont FJ |
FK506 enhances IL-13 production by T cells activated through CD3/CD28. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9363914
|
Motamedi H et al. |
Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506. |
1997 |
Eur. J. Biochem. |
pmid:9063448
|
Taylor PJ et al. |
Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry. |
1997 |
Clin. Chem. |
pmid:9365410
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
Ishida H et al. |
Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. |
1997 |
Toxicology |
pmid:9355935
|
Wang JH and Kelly PT |
Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. |
1997 |
J. Neurophysiol. |
pmid:9356420
|
Lee JW et al. |
Tacrolimus (FK506): validation of a sensitive enzyme-linked immunosorbent assay kit for and application to a clinical pharmacokinetic study. |
1997 |
Ther Drug Monit |
pmid:9108651
|
Thyagarajan GK et al. |
FK506-induced fulminant leukoencephalopathy after single-lung transplantation. |
1997 |
Ann. Thorac. Surg. |
pmid:9386723
|
Holt DW and Johnston A |
Tacrolimus quality assessment. |
1997 |
Ther Drug Monit |
pmid:9108659
|
Wang MS et al. |
Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9262378
|
McElwee KJ et al. |
Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. |
1997 |
Br. J. Dermatol. |
pmid:9390322
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Zhang Q et al. |
A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry. |
1997 |
Ther Drug Monit |
pmid:9263391
|
Huang J and Schreiber SL |
A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. |
1997 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9391035
|
Hikita N et al. |
Use of topical FK506 in a corneal graft rejection model in Lewis rats. |
1997 |
Invest. Ophthalmol. Vis. Sci. |
pmid:9112986
|
Hickman PE et al. |
Clinical chemistry and post-liver-transplant monitoring. |
1997 |
Clin. Chem. |
pmid:9265907
|
Nyanguile O et al. |
A nonnatural transcriptional coactivator. |
1997 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9391036
|
Aicher L et al. |
Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization. |
1997 |
Biochem. Pharmacol. |
pmid:9113092
|
Paterson DL et al. |
Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? |
1997 |
Ann. Neurol. |
pmid:9266742
|
Kageyama S et al. |
Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506. |
1997 |
Acta Virol. |
pmid:9391652
|
Ahsan N et al. |
Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy. |
1997 |
Clin Transplant |
pmid:9113443
|
Yoshimoto T et al. |
[Leukoencephalopathy probably caused by tacrolimus hydrate after stem cell transplantation in a girl with MDS 7 monosomy]. |
1997 |
Rinsho Ketsueki |
pmid:9267167
|
Sokal EM et al. |
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. |
1997 |
Transplantation |
pmid:9392308
|
Singh N et al. |
Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. |
1997 |
Clin. Infect. Dis. |
pmid:9114144
|
Alessiani M et al. |
[Flexibility of the surgical model of intestinal transplantation in swine]. |
1997 |
Minerva Chir |
pmid:9432575
|
Ito E and Tanaka Y |
Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice. |
1997 |
Mycopathologia |
pmid:9433807
|
Boucek MM et al. |
The Registry of the International Society of Heart and Lung Transplantation: first official pediatric report--1997. |
1997 |
J. Heart Lung Transplant. |
pmid:9436131
|
Marienfeld R et al. |
Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. |
1997 |
Eur. J. Immunol. |
pmid:9247567
|
Massicot F et al. |
Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line. |
1997 |
Arch. Toxicol. |
pmid:9248632
|
Newstead CG |
Tacrolimus in renal transplantation. |
1997 |
Nephrol. Dial. Transplant. |
pmid:9249761
|
Neuhaus P et al. |
Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus triple low-dose oral regimens. |
1997 |
Transpl. Int. |
pmid:9249934
|
Dhawan A et al. |
Tacrolimus (FK506) malabsorption: management with fluconazole coadministration. |
1997 |
Transpl. Int. |
pmid:9249946
|
Nagai H et al. |
FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9336339
|
Seifeldin RA et al. |
Nifedipine interaction with tacrolimus in liver transplant recipients. |
1997 |
Ann Pharmacother |
pmid:9161650
|
Homey B et al. |
A local lymph node assay to analyse immunosuppressive effects of topically applied drugs. |
1997 |
Eur. J. Pharmacol. |
pmid:9163567
|
Klupp J et al. |
Mycophenolate mofetil added to immunosuppression after liver transplantation--first results. |
1997 |
Transpl. Int. |
pmid:9163864
|
Gold BG |
FK506 and the role of immunophilins in nerve regeneration. |
1997 |
Mol. Neurobiol. |
pmid:9457703
|
Mignat C |
Clinically significant drug interactions with new immunosuppressive agents. |
1997 |
Drug Saf |
pmid:9113494
|
Bielefeldt K et al. |
Tacrolimus (FK506) modulates calcium release and contractility of intestinal smooth muscle. |
1997 |
Cell Calcium |
pmid:9502200
|
Holt DW and Johnston A |
Monitoring new immunosuppressive agents. Are the methods adequate? |
1997 |
Drug Metabol Drug Interact |
pmid:9713574
|
Shapiro R et al. |
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. |
1997 |
Transplant. Proc. |
pmid:9290809
|
Shaw LM |
Mycophenolate mofetil: pharmacokinetic strategies for optimizing immunosuppression. |
1997 |
Drug Metabol Drug Interact |
pmid:9713576
|
Gruessner AC and Sutherland DE |
Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). |
1997 |
Clin Transpl |
pmid:9919390
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Odorico JS et al. |
Advances in pancreas transplantation: the University of Wisconsin experience. |
1997 |
Clin Transpl |
pmid:9919400
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Nair SC et al. |
Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. |
1997 |
Mol. Cell. Biol. |
pmid:9001212
|
Pirenne J et al. |
Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. |
1997 |
Surgery |
pmid:9001555
|
Felldin M et al. |
Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis. |
1997 |
Transpl. Int. |
pmid:9002146
|
Steiner JP et al. |
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. |
1997 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9050897
|
Seidel ER and Ragan VL |
Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture. |
1997 |
Br. J. Pharmacol. |
pmid:9051292
|
Aoki Y and Kao PN |
Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9177287
|
Prasad NV et al. |
Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone. |
1997 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:9178371
|
Alak AM and Moy S |
Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. |
1997 |
Transplant. Proc. |
pmid:9270821
|
Scholler G et al. |
Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9270822
|
Pichlmayr R et al. |
Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. |
1997 |
Transplant. Proc. |
pmid:9270825
|
Rolfe FG et al. |
Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription. |
1997 |
Am. J. Respir. Cell Mol. Biol. |
pmid:9271313
|
ten Berge RJ and Schellekens PT |
[Immunology in clinical practice. VI. Current immunosuppressive drugs]. |
1997 |
Ned Tijdschr Geneeskd |
pmid:9550813
|
Mayer AD et al. |
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. |
1997 |
Transplantation |
pmid:9275110
|
Guérette B et al. |
Prevention by anti-LFA-1 of acute myoblast death following transplantation. |
1997 |
J. Immunol. |
pmid:9278346
|